These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11261533)

  • 41. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Warfarin-antiretroviral interactions.
    Liedtke MD; Rathbun RC
    Ann Pharmacother; 2009 Feb; 43(2):322-8. PubMed ID: 19196837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Changes in lipid metabolism of patients infected by human immunodeficiency virus. A pathogenic hypothesis].
    Rodríguez Vidigal FF; Muñoz Sanz A
    Med Clin (Barc); 2000 Jun; 115(4):145-50. PubMed ID: 10996887
    [No Abstract]   [Full Text] [Related]  

  • 44. The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection.
    Paik IJ; Kotler DP
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):469-78. PubMed ID: 21663840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
    Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
    HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endocrine and metabolic abnormalities among HIV-infected patients: a current review.
    Kibirige D; Ssekitoleko R
    Int J STD AIDS; 2013 Aug; 24(8):603-11. PubMed ID: 23970578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.
    Gutierrez AD; Balasubramanyam A
    Endocrine; 2012 Feb; 41(1):1-10. PubMed ID: 22134974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.
    Hammer SM; Eron JJ; Reiss P; Schooley RT; Thompson MA; Walmsley S; Cahn P; Fischl MA; Gatell JM; Hirsch MS; Jacobsen DM; Montaner JS; Richman DD; Yeni PG; Volberding PA;
    JAMA; 2008 Aug; 300(5):555-70. PubMed ID: 18677028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy.
    Vidal F; Domingo P; Viladés C; Peraire J; Arnedo M; Alcamí J; Leal M; Villarroya F; Gatell JM
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1365-82. PubMed ID: 21999362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiretroviral therapy with heart.
    Randell P; Moyle G
    Am J Ther; 2009; 16(6):579-84. PubMed ID: 19940610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strategies for treating HIV-related lipodystrophy.
    García-Viejo MA; Ruíz M; Martínez E
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1443-56. PubMed ID: 11772261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin resistance in HIV infection: drugs, host responses, or restoration to health?
    Grunfeld C
    Top HIV Med; 2008; 16(2):89-93. PubMed ID: 18591716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence.
    Willig AL; Overton ET
    Curr HIV/AIDS Rep; 2016 Oct; 13(5):289-96. PubMed ID: 27541600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy.
    Samaras K
    J Acquir Immune Defic Syndr; 2009 Apr; 50(5):499-505. PubMed ID: 19223782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Body composition and metabolic changes in HIV-infected patients.
    Stanley TL; Grinspoon SK
    J Infect Dis; 2012 Jun; 205 Suppl 3(Suppl 3):S383-90. PubMed ID: 22577212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiretroviral treatment for HIV infection/AIDS and the risk of developing hyperglycemia and hyperlipidemia.
    de Araújo PS; de Alencar Ximenes RA; Lopes CF; Duarte JY; da Silva MM; Carneiro EM
    Rev Inst Med Trop Sao Paulo; 2007; 49(2):73-8. PubMed ID: 17505662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients.
    Kim RJ; Rutstein RM
    Paediatr Drugs; 2010 Jun; 12(3):187-99. PubMed ID: 20481647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacologic considerations for therapeutic success with antiretroviral agents.
    Fletcher CV
    Ann Pharmacother; 1999 Sep; 33(9):989-95. PubMed ID: 10492504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protease inhibitor-associated hyperglycemia in Mexican patients with HIV infection.
    Palma-Aguirre A; Halabe-Cherem J; Nellen-Hummel H; Aburto-Mejía E; Ibarra-Herrera E; Ponce-Monter H
    Arch Med Res; 2000; 31(1):81-4. PubMed ID: 10767485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.